Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Shanghai Menon Animal Nutrition Technology
301156
5
Nanjing Railway New Technology
301016
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|
Assets | ||||||||
Current assets | ||||||||
Cash, cash equivalents and short term investments | 61.54%4.56M | 61.54%4.56M | --2.9M | --2.67M | --881K | -26.46%2.82M | --2.82M | --3.84M |
-Cash and cash equivalents | 61.54%4.56M | 61.54%4.56M | --2.9M | --2.67M | --881K | -26.46%2.82M | --2.82M | --3.84M |
Receivables | -36.98%3.18M | -36.98%3.18M | --4.41M | --5.03M | --6.48M | -26.47%5.04M | --5.04M | --6.85M |
-Accounts receivable | -36.98%3.18M | -36.98%3.18M | --4.41M | --5.03M | --6.48M | -26.47%5.04M | --5.04M | --6.85M |
Inventory | -8.40%3.24M | -8.40%3.24M | --2.51M | --3.02M | --4.04M | -17.27%3.54M | --3.54M | --4.27M |
Prepaid assets | 10.67%1.76M | 10.67%1.76M | --1.62M | --2.02M | --1.57M | 8.59%1.59M | --1.59M | --1.47M |
Restricted cash | 0.00%307K | 0.00%307K | --306K | --307K | --307K | 36.44%307K | --307K | --225K |
Current deferred assets | 23.30%471K | 23.30%471K | --657K | --766K | --634K | 402.63%382K | --382K | --76K |
Other current assets | ---1K | ---1K | ---- | ---- | ---- | ---- | ---- | ---- |
Total current assets | -1.22%13.51M | -1.22%13.51M | --12.41M | --13.81M | --13.92M | -18.25%13.68M | --13.68M | --16.73M |
Non current assets | ||||||||
Net PPE | 0.00%21K | 0.00%21K | --24K | --21K | --18K | -56.25%21K | --21K | --48K |
Non current deferred assets | --0 | --0 | --1.95M | --1.08M | --412K | -89.64%148K | --148K | --1.43M |
Total non current assets | -87.57%21K | -87.57%21K | --1.97M | --1.1M | --430K | -88.56%169K | --169K | --1.48M |
Total assets | -2.27%13.53M | -2.27%13.53M | --14.38M | --14.91M | --14.35M | -23.95%13.85M | --13.85M | --18.21M |
Liabilities | ||||||||
Current liabilities | ||||||||
Payables | 19.45%5.66M | 19.45%5.66M | --6.74M | --5.44M | --5.19M | 13.36%4.74M | --4.74M | --4.18M |
-accounts payable | 19.45%5.66M | 19.45%5.66M | --6.74M | --5.44M | --5.19M | 13.36%4.74M | --4.74M | --4.18M |
Current accrued expenses | -73.37%1.47M | -73.37%1.47M | --3.39M | --6.28M | --5.8M | -33.63%5.51M | --5.51M | --8.31M |
Current debt and capital lease obligation | -52.03%5.76M | -52.03%5.76M | --6.37M | --6.81M | --16.42M | -73.00%12.02M | --12.02M | --44.5M |
-Current debt | -52.03%5.76M | -52.03%5.76M | --6.37M | --6.81M | --16.42M | -73.00%12.02M | --12.02M | --44.5M |
Current deferred liabilities | 20.70%3.32M | 20.70%3.32M | --2.25M | --3.04M | --3.56M | -27.60%2.75M | --2.75M | --3.8M |
Other current liabilities | 2.08%2.61M | 2.08%2.61M | --3.54M | --3.51M | --2.53M | 46.72%2.55M | --2.55M | --1.74M |
Current liabilities | -30.10%20.89M | -30.10%20.89M | --25.01M | --27.49M | --35.78M | -54.05%29.89M | --29.89M | --65.04M |
Non current liabilities | ||||||||
Long term debt and capital lease obligation | -12.22%6.19M | -12.22%6.19M | --12.29M | --13.41M | --1.64M | --7.05M | --7.05M | ---- |
-Long term debt | -12.22%6.19M | -12.22%6.19M | --12.29M | --13.41M | --1.64M | --7.05M | --7.05M | ---- |
Non current deferred liabilities | 10.42%318K | 10.42%318K | --1.94M | --1.63M | --179K | -55.07%288K | --288K | --641K |
Non current accrued expenses | 493.48%819K | 493.48%819K | --0 | --0 | --0 | --138K | --138K | --0 |
Derivative product liabilities | ---- | ---- | --3.25M | --232K | ---- | ---- | ---- | ---- |
Preferred securities outside stock equity | --0 | --0 | --68.49M | --112.14M | --112.14M | 66.77%106.95M | --106.95M | --64.13M |
Other non current liabilities | ---- | ---- | --16K | ---- | ---- | ---- | ---- | ---- |
Total non current liabilities | -93.60%7.33M | -93.60%7.33M | --85.98M | --127.42M | --113.97M | 76.67%114.43M | --114.43M | --64.77M |
Total liabilities | -80.45%28.22M | -80.45%28.22M | --110.99M | --154.91M | --149.74M | 11.18%144.32M | --144.32M | --129.81M |
Shareholders'equity | ||||||||
Share capital | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
-common stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Retained earnings | -7.72%-290.4M | -7.72%-290.4M | ---286.77M | ---286.57M | ---281.83M | -5.08%-269.58M | ---269.58M | ---256.54M |
Paid-in capital | 98.29%275.38M | 98.29%275.38M | --189.97M | --146.23M | --146.13M | -4.07%138.88M | --138.88M | --144.78M |
Gains losses not affecting retained earnings | 44.30%329K | 44.30%329K | --193K | --339K | --302K | 39.02%228K | --228K | --164K |
Total stockholders'equity | 88.74%-14.69M | 88.74%-14.69M | ---96.61M | ---140M | ---135.39M | -16.91%-130.47M | ---130.47M | ---111.6M |
Total equity | 88.74%-14.69M | 88.74%-14.69M | ---96.61M | ---140M | ---135.39M | -16.91%-130.47M | ---130.47M | ---111.6M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- |